The 175 MM patients included in this study had an average age of 62.36 ± 8.76 (76 of them, 43.43% were male) and a median of 0.10 pg/ml IL-17A, 104 (59.43%) exhibited baseline bone lesions at the time of initial onset, and 38 (21.84%) had fractures. This evidence concerns the gene IL17A and Miyoshi myopathy.